Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome is characterized by phocomelia (involving arms more severely), ectrodactyly, ear anomalies (bilateral anomalies of the pinnae), conductive deafness, dysmorphism (long and prominent philtrum, mild maxillary hypoplasia) and sinus arrhythmia. It has been described in four patients (a father and his son and a mother and her daughter) from two unrelated families.
Biomarker and diagnostic research for phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome has been reported in the published literature.
No clinical trials have been registered for phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome.
299 publications have been identified in PubMed for phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome. Kisho has analyzed 136 by research type. Research spans Review / Meta-Analysis (57%), Basic Science / Preclinical (15%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 77 | 57% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
20 |
15% |
Disease patterns and progression | 15 | 11% |
Clinical study results | 9 | 7% |
Testing and diagnosis research | 8 | 6% |
Patient case studies | 4 | 3% |
New treatment approaches | 2 | 1% |
Other research | 1 | 1% |
Brunt TM (2026). [PMID: 41560340](https://pubmed.ncbi.nlm.nih.gov/41560340/). *Addiction*. [Review / Meta-Analysis]
Wejner-Mik P (2026). [PMID: 41589835](https://pubmed.ncbi.nlm.nih.gov/41589835/). *Kardiol Pol*. [Review / Meta-Analysis]
Grisorio L (2026). [PMID: 41534743](https://pubmed.ncbi.nlm.nih.gov/41534743/). *Can J Cardiol*. [Review / Meta-Analysis]
Reinert MS (2026). [PMID: 41568438](https://pubmed.ncbi.nlm.nih.gov/41568438/). *Circulation*. [Epidemiology / Natural History]
Mascia G (2026). [PMID: 41380380](https://pubmed.ncbi.nlm.nih.gov/41380380/). *J Electrocardiol*. [Review / Meta-Analysis]
Guazzo A (2026). [PMID: 41411472](https://pubmed.ncbi.nlm.nih.gov/41411472/). *JACC Clin Electrophysiol*. [Basic Science / Preclinical]
Moore BM (2026). [PMID: 41342099](https://pubmed.ncbi.nlm.nih.gov/41342099/). *Circulation*. [Diagnostic / Biomarker]
Poudel J (2026). [PMID: 41511846](https://pubmed.ncbi.nlm.nih.gov/41511846/). *South Med J*. [Review / Meta-Analysis]
Warrings W (2026). [PMID: 41004670](https://pubmed.ncbi.nlm.nih.gov/41004670/). *Ther Drug Monit*. [Clinical Trial Publication]
Manolis TA (2026). [PMID: 41350148](https://pubmed.ncbi.nlm.nih.gov/41350148/). *Eur J Intern Med*. [Review / Meta-Analysis]